CYTOCHALASIN B

CYTOCHALASIN B is a lipid of Polyketides (PK) class. Cytochalasin b is associated with abnormalities such as Renal tubular disorder and Chagas Disease. The involved functions are known as Membrane Protein Traffic, inhibitors, Metabolic Inhibition, Biochemical Pathway and Increased Sensitivy. Cytochalasin b often locates in Cytoplasmic matrix, Plasma membrane, Microtubules, Extracellular and Protoplasm. The associated genes with CYTOCHALASIN B are SLC2A2 gene, PFDN5 gene, SLC2A1 gene, OMG gene and SPEN gene. The related lipids are Steroids, Lipopolysaccharides and Liposomes. The related experimental models are Xenograft Model.

Cross Reference

Introduction

To understand associated biological information of CYTOCHALASIN B, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with CYTOCHALASIN B?

CYTOCHALASIN B is suspected in Renal tubular disorder, Chagas Disease and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with CYTOCHALASIN B

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Tuberculosis D014376 20 associated lipids
Uremia D014511 33 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Adenocarcinoma D000230 166 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lung Neoplasms D008175 171 associated lipids
Wounds and Injuries D014947 20 associated lipids
Adenoma, Islet Cell D007516 7 associated lipids
Insulinoma D007340 28 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Body Weight D001835 333 associated lipids
Foreign-Body Reaction D005549 10 associated lipids
Granulomatous Disease, Chronic D006105 4 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Melanoma D008545 69 associated lipids
Asthma D001249 52 associated lipids
Kidney Diseases D007674 29 associated lipids
Glioma D005910 112 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Lymphoma D008223 18 associated lipids
Alzheimer Disease D000544 76 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Eye Diseases D005128 12 associated lipids
Arteriosclerosis D001161 86 associated lipids
Leukemia D007938 74 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Lymphoproliferative Disorders D008232 7 associated lipids
Leukemia, Myelogenous, Chronic, BCR-ABL Positive D015464 17 associated lipids
Hypoglycemia D007003 13 associated lipids
Starvation D013217 47 associated lipids
Leukemia, Myeloid D007951 52 associated lipids
Birth Weight D001724 23 associated lipids
Hypertension D006973 115 associated lipids
Pituitary Neoplasms D010911 4 associated lipids
Tongue Neoplasms D014062 15 associated lipids
Leukemia, Experimental D007942 42 associated lipids
Galactosemias D005693 5 associated lipids
Thrombocytopenia D013921 15 associated lipids
Burkitt Lymphoma D002051 15 associated lipids
Leukemia, Lymphoid D007945 18 associated lipids
Carbon Monoxide Poisoning D002249 9 associated lipids
Neutropenia D009503 15 associated lipids
Chondrosarcoma D002813 9 associated lipids
Anemia D000740 21 associated lipids
Hyperinsulinism D006946 27 associated lipids
Congenital Abnormalities D000013 11 associated lipids
Carcinoma 256, Walker D002279 22 associated lipids
Thymus Neoplasms D013953 15 associated lipids
Wiskott-Aldrich Syndrome D014923 3 associated lipids
Erythroblastosis, Fetal D004899 2 associated lipids
Micronuclei, Chromosome-Defective D048629 33 associated lipids
Medulloblastoma D008527 22 associated lipids
Systemic Inflammatory Response Syndrome D018746 4 associated lipids
Insulin Resistance D007333 99 associated lipids
Aggressive Periodontitis D010520 8 associated lipids
Glucose Intolerance D018149 13 associated lipids
Granulomatosis with Polyangiitis D014890 5 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Endometrial Neoplasms D016889 30 associated lipids
Malaria, Falciparum D016778 22 associated lipids
Lymphoma, B-Cell D016393 24 associated lipids
Lymphoma, T-Cell D016399 11 associated lipids
Cell Transformation, Viral D002472 26 associated lipids
Infectious Mononucleosis D007244 5 associated lipids
Ataxia Telangiectasia D001260 6 associated lipids
Pharyngeal Neoplasms D010610 4 associated lipids
Coronavirus Infections D018352 4 associated lipids
Chancroid D002602 4 associated lipids
Trisomy D014314 6 associated lipids
CREST Syndrome D017675 2 associated lipids
Factor XII Deficiency D005175 2 associated lipids
Per page 10 20 50 100 | Total 79

PubChem Associated disorders and diseases

What pathways are associated with CYTOCHALASIN B

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with CYTOCHALASIN B?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with CYTOCHALASIN B?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with CYTOCHALASIN B?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with CYTOCHALASIN B?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with CYTOCHALASIN B?

Xenograft Model

Xenograft Model are used in the study 'Endofacial competitive inhibition of the glucose transporter 1 activity by gossypol.' (Pérez A et al., 2009).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with CYTOCHALASIN B

Download all related citations
Per page 10 20 50 100 | Total 4982
Authors Title Published Journal PubMed Link
Westfall MV and Sayeed MM Effect of diltiazem on skeletal muscle 3-O-methylglucose transport in bacteremic rats. 1989 Am. J. Physiol. pmid:2646956
Betz AL et al. Hexose transport and phosphorylation by capillaries isolated from rat brain. 1979 Am. J. Physiol. pmid:434144
Fushiki T et al. Changes in glucose transporters in muscle in response to exercise. 1989 Am. J. Physiol. pmid:2655468
Nishimura H et al. Postreceptor defect in insulin action in streptozotocin-induced diabetic rats. 1989 Am. J. Physiol. pmid:2655470
Cheeseman CI and Maenz DD Rapid regulation of D-glucose transport in basolateral membrane of rat jejunum. 1989 Am. J. Physiol. pmid:2655474
Ciaraldi TP et al. Insulin-stimulated glucose transport in human adipocytes. 1979 Am. J. Physiol. pmid:443417
King PA et al. Glucose transport in skeletal muscle membrane vesicles from control and exercised rats. 1989 Am. J. Physiol. pmid:2610251
Garland A et al. Activated eosinophils elicit substance P release from cultured dorsal root ganglion neurons. 1997 Am. J. Physiol. pmid:9374740
Mills JW and Lubin M Effect of adenosine 3',5'-cyclic monophosphate on volume and cytoskeleton of MDCK cells. 1986 Am. J. Physiol. pmid:3006500
Feuilloley M et al. Effects of selective disruption of cytoskeletal elements on steroid secretion by human adrenocortical slices. 1994 Am. J. Physiol. pmid:8141278
Foley JE et al. Glucose transport in isolated rat adipocytes with measurements of L-arabinose uptake. 1978 Am. J. Physiol. pmid:623288
Renfro JL and Shustock E Peritubular uptake and brush border transport of 28Mg by flounder renal tubules. 1985 Am. J. Physiol. pmid:2413774
Rosholt MN et al. High-fat diet reduces glucose transporter responses to both insulin and exercise. 1994 Am. J. Physiol. pmid:8304561
Johnson LW and Smith CH Monosaccharide transport across microvillous membrane of human placenta. 1980 Am. J. Physiol. pmid:6990781
Muller J and Kachadorian WA Aggregate-carrying membranes during ADH stimulation and washout in toad bladder. 1984 Am. J. Physiol. pmid:6430101
Pearl M and Taylor A Actin filaments and vasopressin-stimulated water flow in toad urinary bladder. 1983 Am. J. Physiol. pmid:6307056
Reshkin SJ and Ahearn GA Basolateral glucose transport by intestine of teleost, Oreochromis mossambicus. 1987 Am. J. Physiol. pmid:3030144
Kasbekar DK and Gordon GS Effects of colchicine and vinblastine on in vitro gastric secretion. 1979 Am. J. Physiol. pmid:312607
Mullin JM et al. Basolateral 3-O-methylglucose transport by cultured kidney (LLC-PK1) epithelial cells. 1992 Am. J. Physiol. pmid:1558165
Mercado CL et al. Enhanced glucose transport in response to inhibition of respiration in Clone 9 cells. 1989 Am. J. Physiol. pmid:2750888
Schneyer LH Differential effects of cytochalasin B on Na and K transport in a perfused salivary duct. 1974 Am. J. Physiol. pmid:4412815
Malaisse WJ et al. Insulinotropic action of alpha-D-glucose pentaacetate: functional aspects. 1997 Am. J. Physiol. pmid:9435523
Fushiki T et al. Decrease in muscle glucose transporter number in chronic physical inactivity in rats. 1991 Am. J. Physiol. pmid:1672241
Sternlicht E et al. Mechanism of insulin action on glucose transport in rat skeletal muscle. 1988 Am. J. Physiol. pmid:3284385
Lipowsky HH et al. Leukocyte rolling velocity and its relation to leukocyte-endothelium adhesion and cell deformability. 1996 Am. J. Physiol. pmid:8967378
Peralta Soler A et al. Tissue remodeling during tumor necrosis factor-induced apoptosis in LLC-PK1 renal epithelial cells. 1996 Am. J. Physiol. pmid:8928850
Uemura N et al. Decreased secretion due to a Ca2+ influx defect in frog peptic cells isolated with EGTA. 1990 Am. J. Physiol. pmid:2159219
Grinstein S et al. Phorbol ester-induced changes of cytoplasmic pH in neutrophils: role of exocytosis in Na+-H+ exchange. 1985 Am. J. Physiol. pmid:2579574
Stetson DL and Steinmetz PR Role of membrane fusion in CO2 stimulation of proton secretion by turtle bladder. 1983 Am. J. Physiol. pmid:6408926
Kimmich GA et al. Energetics of Na+-dependent sugar transport by isolated intestinal cells: evidence for a major role for membrane potentials. 1977 Am. J. Physiol. pmid:562624
Tseng S et al. F-actin disruption attenuates agonist-induced [Ca2+], myosin phosphorylation, and force in smooth muscle. 1997 Am. J. Physiol. pmid:9227425
Salans LB et al. Effects of dietary composition on glucose metabolism in rat adipose cells. 1981 Am. J. Physiol. pmid:7008628
Karnieli E et al. Discrepancy between glucose transport and transporters in human femoral adipocytes. 1989 Am. J. Physiol. pmid:2643341
Ajubi NE et al. Signal transduction pathways involved in fluid flow-induced PGE2 production by cultured osteocytes. 1999 Am. J. Physiol. pmid:9886964
Longo N et al. Influx and efflux of 3-O-methyl-D-glucose by cultured human fibroblasts. 1988 Am. J. Physiol. pmid:3364550
Cheung PT and Hammerman MR Na+-independent D-glucose transport in rabbit renal basolateral membranes. 1988 Am. J. Physiol. pmid:3364579
Wan X et al. Activation of mechanosensitive currents in traumatized membrane. 1999 Am. J. Physiol. pmid:9950759
Wade JB and Kachadorian WA Cytochalasin B inhibition of toad bladder apical membrane responses to ADH. 1988 Am. J. Physiol. pmid:3140672
Kimmich GA and Randles J Energetics of sugar transport by isolated intestinal epithelial cells: effects of cytochalasin B. 1979 Am. J. Physiol. pmid:464042
O'Flaherty JT et al. Neutrophil-degranulating action of 5,12-dihydroxy-6,8,10,14-eicosatetraenoic acid and 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine. Comparison with other degranulating agents. 1981 Am. J. Pathol. pmid:6274199
Aikawa M et al. Interactions between macrophagelike cells and Leishmania braziliensis in vitro. 1982 Am. J. Pathol. pmid:7091302
Elbim C et al. Heterogeneity in Lewis-X and sialyl-Lewis-X antigen expression on monocytes in whole blood: relation to stimulus-induced oxidative burst. 1998 Am. J. Pathol. pmid:9546369
Russo MA et al. Ultrastruct pathology of phalloidin-intoxicated hepatocytes in the presence and absence of extracellular calcium. 1982 Am. J. Pathol. pmid:6890315
Fantone JC et al. Stimulus specificity of prostaglandin inhibition of rabbit polymorphonuclear leukocyte lysosomal enzyme release and superoxide anion production. 1984 Am. J. Pathol. pmid:6324595
Okayasu T et al. Cytochalasin delays but does not prevent cell death from anoxia. 1984 Am. J. Pathol. pmid:6541879
Becker EL et al. Superoxide production induced in rabbit polymorphonuclear leukocytes by synthetic chemotactic peptides and A23187. 1979 Am. J. Pathol. pmid:219701
Díaz-Ricart M et al. Inhibition of cytoskeletal assembly by cytochalasin B prevents signaling through tyrosine phosphorylation and secretion triggered by collagen but not by thrombin. 2002 Am. J. Pathol. pmid:11786426
O'Flaherty JT et al. Neutrophil aggregation and degranulation. Effect of arachidonic acid. 1979 Am. J. Pathol. pmid:453323
Matsumura N et al. Stable expression in Chinese hamster ovary cells of mutated tau genes causing frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). 1999 Am. J. Pathol. pmid:10362789
O'Flaherty JT et al. 1-O-Alkyl-sn-glyceryl-3-phosphorylcholines: a novel class of neutrophil stimulants. 1981 Am. J. Pathol. pmid:7223864
O'Flaherty JT et al. Substances which aggregate neutrophils. Mechanism of action. 1978 Am. J. Pathol. pmid:356621
Ward PA et al. Rat neutrophil activation and effects of lipoxygenase and cyclooxygenase inhibitors. 1984 Am. J. Pathol. pmid:6087668
Hsu LS and Becker EL Volume changes induced in rabbit polymorphonuclear leukocytes by chemotactic factor and cytochalasin B. 1975 Am. J. Pathol. pmid:1180327
Ohta M et al. Changes in the organization and antigenic determinants of intermediate filaments of rat hepatocytes after infusion of cytochalasin B in vivo. 1988 Am. J. Pathol. pmid:2462355
White JG and Estensen RD Cytochemical electron microscopic studies of the action of phorbol myristate acetate on platelets. 1974 Am. J. Pathol. pmid:4814897
Ulevitch RJ et al. Hyperexpression of interferon-gamma-induced MHC class II genes associated with reorganization of the cytoskeleton. 1991 Am. J. Pathol. pmid:1907805
Lanni C and Becker EL Release of phospholipase A2 activity from rabbit peritoneal neutrophils by f-Met-Leu-Phe. 1983 Am. J. Pathol. pmid:6624881
Ogawa H et al. Comparative study of eosinophil and neutrophil chemotaxis and enzyme release. 1981 Am. J. Pathol. pmid:7294162
O'Flaherty JT et al. Role of extracellular calcium and neutrophil degranulation responses to 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine. 1981 Am. J. Pathol. pmid:6271016
Holland JA et al. Atherogenic levels of low-density lipoprotein increase endocytotic activity in cultured human endothelial cells. 1992 Am. J. Pathol. pmid:1546741
Mease AD et al. Irreversible neutrophil aggregation. A mechanism of decreased newborn neutrophil chemotactic response. 1981 Am. J. Pathol. pmid:7258298
White JG and Rao GH Microtubule coils versus the surface membrane cytoskeleton in maintenance and restoration of platelet discoid shape. 1998 Am. J. Pathol. pmid:9466587
Ingram DA et al. Phagocytic activation of human neutrophils by the detergent component of fluosol. 1992 Am. J. Pathol. pmid:1316083
Mukherjee C and Lynn WS Role of ions and extracellular protein in leukocyte motility and membrane ruffling. 1978 Am. J. Pathol. pmid:717536
Schollmeyer JV et al. An actin-binding protein in human platelets. Interactions with alpha-actinin on gelatin of actin and the influence of cytochalasin B. 1978 Am. J. Pathol. pmid:717537
Webster RO et al. Enhancement of human polymorphonuclear leukocyte adherence to plastic and endothelium by phorbol myristate acetate. Comparison with human C5a. 1986 Am. J. Pathol. pmid:3789092
Ginsberg M et al. Mechanisms of platelet response to monosodium urate crystals. 1979 Am. J. Pathol. pmid:426039
Escolar G et al. Organization of the actin cytoskeleton of resting and activated platelets in suspension. 1986 Am. J. Pathol. pmid:2870643
White JG et al. Glycoprotein Ib is homogeneously distributed on external and internal membranes of resting platelets. 1999 Am. J. Pathol. pmid:10595941
Wysolmerski RB and Lagunoff D Inhibition of endothelial cell retraction by ATP depletion. 1988 Am. J. Pathol. pmid:3394800
Liu S et al. Dynamic modulation of cytoskeleton during in vitro maturation in human oocytes. 2010 Am. J. Obstet. Gynecol. pmid:20579967
Kniss DA et al. Expression of functional insulin-like growth factor-I receptors by human amnion cells. 1993 Am. J. Obstet. Gynecol. pmid:8372873
Sato N et al. Hyposmolarity stimulates myeloperoxidase exocytosis from human polymorphonuclear leukocytes. 1990 Am. J. Med. Sci. pmid:2159710
Mooradian AD and Morin AM Brain uptake of glucose in diabetes mellitus: the role of glucose transporters. 1991 Am. J. Med. Sci. pmid:2000888
Jacobs DB Fat cells: model system to investigate molecular mechanism(s) of sulfonylurea-potentiated glucose transport. 1985 Am. J. Med. pmid:3931463
Wann JG et al. Enhanced expression of glucose transporter 1 on erythrocyte membrane in hemodialysis patients: the possible role in erythrocyte ascorbate recycling. 2006 Am. J. Kidney Dis. pmid:16731301
Standley PR and Rose KA Insulin and insulin-like growth factor-1 modulation of glucose transport in arterial smooth muscle cells: implication of GLUT-4 in the vasculature. 1994 Am. J. Hypertens. pmid:8031552
Berkow RL and Dodson RW Functional analysis of the marginating pool of human polymorphonuclear leukocytes. 1987 Am. J. Hematol. pmid:3026170
Stagno PA and Low FN Effects of cytochalasin B on the fine structure of organized endodermal cells of the early chick embryo. 1978 Am. J. Anat. pmid:626150
Nicosia SV and Tojo R Morphogenetic reaggregation and luteinization of mouse preantral follicle cells. 1979 Am. J. Anat. pmid:532792
Rhoten WB Emiocytosis of B granules from saurian pancreatic islets perifused in vitro. 1973 Am. J. Anat. pmid:4585905
Bondareff W and Tuttle RL Cortical cytoplasm and configurational changes of RGC-6 cells exposed to cytochalasin B. 1975 Am. J. Anat. pmid:1211367
Holtzer H et al. Effects of cytochalasin-B and colcimide on cells in muscle cultures. 1974 Am. J. Anat. pmid:4413125
Holtzer H et al. Effects of Cytochalasin-B and colcimide on cells in muscle cultures. 1974 Am. J. Anat. pmid:4440631
Webster W and Langman J The effect of cytochalasin B on the neuroepithelial cells of the mouse embryo. 1978 Am. J. Anat. pmid:567005
Harik SI et al. The hexose transporter of human erythrocytes in aging and Alzheimer dementia. 1989 Alzheimer Dis Assoc Disord pmid:2597423
Zeck-Kapp G et al. Mechanisms of human eosinophil activation by complement protein C5a and platelet-activating factor: similar functional responses are accompanied by different morphologic alterations. 1995 Allergy pmid:7741187
Takafuji S et al. Effects of interleukin (IL)-3 and IL-5 on human eosinophil degranulation induced by complement components C3a and C5a. 1996 Allergy pmid:8874660
Hückel C et al. [The role of the cytoskeleton in lymphocyte stimulation]. 1985 Allerg Immunol (Leipz) pmid:3161315
Lundqvist C et al. Agonist-stimulated and basal phosphatidylethanol formation in neutrophils from alcoholics. 1994 Alcohol. Clin. Exp. Res. pmid:7943658
Wei M et al. [Analysis of gene expression patterns of leukemia K562 cells after cytochalasin B treatment]. 2003 Ai Zheng pmid:12654177
Naef A The relationship between the transient cAMP peak and various leucocyte responses. 1983 Agents Actions Suppl. pmid:6301236
Albinus M and Mayer B The effects of antimitotic and microfilament disrupting agents on functions of isolated guinea-pig parietal cells. 1985 Agents Actions pmid:4040314
Baggiolini M et al. Effect of benzydamine on exocytosis and respiratory burst in human neutrophils and mononuclear phagocytes. 1985 Agents Actions pmid:2996321
Fantozzi R et al. FMLP-activated neutrophils evoke histamine release from mast cells. 1986 Agents Actions pmid:2425573
Tasaka K et al. Distribution of actin filaments in rat mast cells and its role in histamine release. 1986 Agents Actions pmid:2425590
Mannaioni PF et al. Studies on the 14C-histamine release induced by noradrenaline in mouse neoplastic mast cells. 1975 Agents Actions pmid:56875
Moroni F et al. Studies on the 14C-histamine release induced by histamine in mouse neoplastic mast cells. 1975 Agents Actions pmid:56876
Schnitzler S et al. Histamine release from rat mast cells induced by protamine sulfate and polyethylene imine. 1981 Agents Actions pmid:6166172
Roos D et al. Dissociation of phagocytosis, metabolic stimulation and lysosomal enzyme release in human leukocytes. 1976 Agents Actions pmid:181968